Medicure (MCUJF) Receivables (2009 - 2026)

Medicure's Receivables history runs 18 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• On a quarterly basis, Receivables rose 33.39% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.1 million, a 33.39% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, down 9.75% from the prior year.
• Receivables advanced to $4.1 million in Q1 2026 per MCUJF's latest filing, from $3.5 million in the prior quarter.
• Across five years, Receivables topped out at $4.8 million in Q3 2024 and bottomed at $3.1 million in Q1 2025.
• The 5-year median for Receivables is $4.0 million (2022), against an average of $4.0 million.
• Across the five-year window, Receivables sank 32.37% in 2025 and soared 33.39% in 2026, its largest moves.
• Year by year, Receivables stood at $4.2 million in 2022, then retreated by 10.41% to $3.8 million in 2023, then increased by 0.68% to $3.8 million in 2024, then slipped by 7.74% to $3.5 million in 2025, then gained by 17.73% to $4.1 million in 2026.
• Per Business Quant, the three latest MCUJF Receivables figures stand at $4.1 million (Q1 2026), $3.5 million (Q4 2025), and $3.3 million (Q3 2025).